Schools
2 Greenwich Students Are Finalists In Regeneron Science Talent Search
Regeneron Science Talent Search is the nation's oldest and most prestigious science and math competition for high school seniors.

GREENWICH, CT — Society for Science announced this week that Greenwich High School seniors Angie Fogarty and Ambika Grover were included the top 40 finalists in this year’s Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.
Both GHS finalists will participate in a week-long competition in March 2023, during which they will undergo a rigorous judging process that goes beyond their own research to encompass other scientific disciplines and compete for more than $1.8 million in awards.
They will also have an opportunity to interact with leading scientists and share their research during a virtual "Public Day" event on March 12. The top 10 Regeneron Science Talent Search 2023 winners will be announced during an awards ceremony on March 14, streamed live from Washington, D.C.
Find out what's happening in Greenwichfor free with the latest updates from Patch.
"Being selected as a Regeneron Science Talent Search Finalist places Angie and Ambika in the company with so many talented, young scientists that have become leaders in science and technology, including 13 Nobel Prize winners, and 22 MacArthur Foundation Fellows," said Science Research & Junior Innovators teacher at GHS Andy Bramante. "With these visionaries, Angie and Ambika share their love for scientific discovery for the most profound reason: their desire to apply their innate gifts of technological imagination, creativity, and persistence to help others. I'm so incredibly proud of these two amazing young ladies!"
Fogarty's project is titled "Rapid, Visual Detection of Illicit Substances in a Variety of Environments via Competitive, Amine-Responsive Fluorophores."
Find out what's happening in Greenwichfor free with the latest updates from Patch.
Grover's project is "Design of a Novel, Dual-Functioning, Tissue Plasminogen Activator and Factor XI-Inhibiting Anticoagulant Therapeutic for Rapid Ischemic Stroke Treatment."
The finalists were chosen based on their projects’ scientific rigor and their potential to become world-changing scientific leaders.
Finalists were selected by a national jury of professional scientists from a pool of 300 scholars, who were announced earlier this month. The scholars were named from a pool of over 1,900 highly-qualified entrants, all of whom completed an original research project and extensive application process.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.